Intravenous azacitidine for MDS

Steven D. Gore

Intravenous azacitidine for MDS

Steven D. Gore

Research output: Contribution to journal › Review article › peer-review

Original language	English (US)
Pages (from-to)	234
Number of pages	1
Journal	Clinical Advances in Hematology and Oncology
Volume	5
Issue number	3
State	Published - Mar 2007
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology

Cite this

@article{405efbe55828433b8c8b6d838a5099fc,

title = "Intravenous azacitidine for MDS",

author = "Gore, {Steven D.}",

note = "Funding Information: The authors would like to thank Alberto Garcia, Gary Hubbard, Ken St. Hilaire, Keith Penney, and Sal Birtola for their dedicated support of the DISI laboratory. Also, thanks to Drs. W. Ethan Eagle and Kan Zha for helpful discussions and for reviewing this paper. The work was performed at the Combustion Research Facility, Sandia National Laboratories, Livermore, CA. Financial support was provided by the U.S. Department of Energy, Office of Vehicle Technologies. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. Dr. Zongjie Hu's visit was financially supported by China Scholarship Council, and National Natural Science Foundation of China (Project no. 51106113 ).",

year = "2007",

month = mar,

language = "English (US)",

volume = "5",

pages = "234",

journal = "Clinical Advances in Hematology and Oncology",

issn = "1543-0790",

publisher = "Millennium Medical Publishing, Inc.",

number = "3",

}

TY - JOUR

T1 - Intravenous azacitidine for MDS

AU - Gore, Steven D.

N1 - Funding Information: The authors would like to thank Alberto Garcia, Gary Hubbard, Ken St. Hilaire, Keith Penney, and Sal Birtola for their dedicated support of the DISI laboratory. Also, thanks to Drs. W. Ethan Eagle and Kan Zha for helpful discussions and for reviewing this paper. The work was performed at the Combustion Research Facility, Sandia National Laboratories, Livermore, CA. Financial support was provided by the U.S. Department of Energy, Office of Vehicle Technologies. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. Dr. Zongjie Hu's visit was financially supported by China Scholarship Council, and National Natural Science Foundation of China (Project no. 51106113 ).

PY - 2007/3

Y1 - 2007/3

UR - http://www.scopus.com/inward/record.url?scp=34247505561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247505561&partnerID=8YFLogxK

M3 - Review article

C2 - 17519884

AN - SCOPUS:34247505561

VL - 5

SP - 234

JO - Clinical Advances in Hematology and Oncology

JF - Clinical Advances in Hematology and Oncology

SN - 1543-0790

IS - 3

ER -

Intravenous azacitidine for MDS

ASJC Scopus subject areas

Other files and links

Cite this